| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $76.3M | -19.9% |
| Cost of Revenue | $59.9M | -14.5% |
| Gross Profit | $16.4M | -34.9% |
| R&D Expense | $12.0M | +6.2% |
| SG&A Expense | $56.0M | -15.3% |
| Operating Income | -$57.2M | -9.5% |
| Pre-tax Income | -$46.4M | -18.2% |
| Net Income | -$46.4M | -18.2% |
| EPS (Basic) | -$122.12 | -1622.4% |
| EPS (Diluted) | -$122.12 | -1622.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $10.2M | -39.1% |
| Inventory | $21.9M | -45.6% |
| Current Assets | $33.5M | -44.3% |
| Total Assets | $51.8M | -38.3% |
| Current Liabilities | $60.1M | +18.5% |
| Total Liabilities | $61.5M | +13.5% |
| Stockholders' Equity | -$9.7M | -132.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | +86.4% |
| Capital Expenditures | $2.5M | -50.7% |
| Investing Cash Flow | -$2.6M | +48.5% |
| Financing Cash Flow | $6.2M | -83.5% |
| Free Cash Flow | -$7.6M | +82.1% |